Literature DB >> 24200128

Fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis of infected aortic aneurysms.

Masanori Murakami1, Noriyasu Morikage2, Makoto Samura2, Osamu Yamashita2, Kotaro Suehiro2, Kimikazu Hamano2.   

Abstract

BACKGROUND: Infected aortic aneurysms are diagnosed on the basis of a positive bacterial blood culture, clinical evidence of inflammation, and morphologic findings on computed tomography (CT). However, preoperative diagnosis is often difficult because blood cultures are frequently negative and patients can be asymptomatic. Because therapeutic approaches differ significantly, it is vital to determine whether an aortic aneurysm is infected prior to surgery.
METHODS: From June 2007 to July 2012, we investigated 11 cases of suspected infected aortic aneurysm using fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG-PET/CT). In addition to contrast-enhanced CT examination, blood culture and histologic examinations were performed to aid diagnosis.
RESULTS: Patients with a final diagnosis of infected aortic aneurysms showed a maximum standard uptake value (SUVmax) of >4.46, whereas infection-free cases had an SUVmax of <2.59 (mean 6.5 ± 1.8 vs. 1.9 ± 0.5; P < 0.001).
CONCLUSION: FDG-PET/CT examination is useful in the diagnosis of infected aortic aneurysms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24200128     DOI: 10.1016/j.avsg.2013.04.013

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  10 in total

Review 1.  Inflammatory and infectious aortic diseases.

Authors:  Amy R Deipolyi; Christopher D Czaplicki; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

Review 2.  Cross-sectional imaging of aortic infections.

Authors:  D J Murphy; A R Keraliya; M D Agrawal; A Aghayev; M L Steigner
Journal:  Insights Imaging       Date:  2016-10-19

3.  Metabolic Imaging as a Novel Strategy in Evaluation of Mycotic Abdominal Aortic Aneurysm: A Case Report and Brief Clinical Review.

Authors:  Akshay Sharad Bedmutha; Natasha Singh; Divya Shivdasani
Journal:  Indian J Nucl Med       Date:  2017 Oct-Dec

4.  Total resection of an infected aortic arch aneurysm caused by Mycobacterium avium: a case report.

Authors:  Kei Yagami; Takashi Fujita; Shinichi Ishida; Masato Mutsuga
Journal:  J Cardiothorac Surg       Date:  2019-08-19       Impact factor: 1.637

5.  Aspergillus thromboembolism from a mycotic ascending aortic pseudoaneurysm.

Authors:  Afshin A Skibba; Michael R West; James R Evans; Steven P Hopkins; Simon Maltais; Daniel S Rush
Journal:  J Vasc Surg Cases       Date:  2015-04-21

6.  Aortic sarcoma mimicking a mycotic aneurysm in the thoracoabdominal aorta.

Authors:  Tatsuya Shimogawara; Shigeshi Ono; Kanako Kobayashi; Aya Sasaki; Hideyuki Shimizu; Junichi Matsui
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-12-04

Review 7.  Vascular findings on FDG PET/CT.

Authors:  Stephen Liddy; Andrew Mallia; Conor D Collins; Ronan P Killeen; Stephen Skehan; Jonathan D Dodd; Manil Subesinghe; David J Murphy
Journal:  Br J Radiol       Date:  2020-05-06       Impact factor: 3.039

Review 8.  Role of PET/CT in the Evaluation of Aortic Disease.

Authors:  Jahae Kim; Ho-Chun Song
Journal:  Chonnam Med J       Date:  2018-09-27

Review 9.  PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders.

Authors:  William Y Raynor; Peter Sang Uk Park; Austin J Borja; Yusha Sun; Thomas J Werner; Sze Jia Ng; Hui Chong Lau; Poul Flemming Høilund-Carlsen; Abass Alavi; Mona-Elisabeth Revheim
Journal:  Diagnostics (Basel)       Date:  2021-11-29

Review 10.  Prospect of positron emission tomography for abdominal aortic aneurysm risk stratification.

Authors:  Richa Gandhi; Michael Bell; Marc Bailey; Charalampos Tsoumpas
Journal:  J Nucl Cardiol       Date:  2021-05-11       Impact factor: 5.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.